pentoxifylline has been researched along with Endothelioma, Lymphatic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Weiss, JM | 1 |
| Vanscheidt, W | 1 |
| Pilarski, KA | 1 |
| Weyl, A | 1 |
| Peschen, M | 1 |
| Schöpf, E | 1 |
| Vestweber, D | 1 |
| Simon, JC | 1 |
1 other study available for pentoxifylline and Endothelioma, Lymphatic
| Article | Year |
|---|---|
Pentoxifylline inhibits tumor necrosis factor-alpha (TNF alpha)-induced T-lymphoma cell adhesion to endothelioma cells.
Topics: Animals; Cell Adhesion; Cell Line; Lymphangioma; Lymphoma, T-Cell, Cutaneous; Mice; Pentoxifylline; | 1995 |